Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Molecular Biology
Investigating The Runx1-Cbfβ Transcription Factor Complex As A Mitotic Gene Bookmark To Maintain The Normal Mammary Epithelial Phenotype, Eliana Moskovitz
Investigating The Runx1-Cbfβ Transcription Factor Complex As A Mitotic Gene Bookmark To Maintain The Normal Mammary Epithelial Phenotype, Eliana Moskovitz
Graduate College Dissertations and Theses
Disruption of normal mammary epithelial cell homeostasis through acquisition of
deleterious somatic and/or germline mutations leads to breast cancer development. Breast
cancer is the most commonly diagnosed cancer among women worldwide, and is
associated with the second highest amount of cancer-related deaths. Breast cancer
mortality rates are decreasing, likely through increased methods of detection and
development of targeted therapies. However, due to the complexity and heterogeneity of
the disease, the incidence rate remains high and the molecular events that lead to breast
cancer initiation and progression are poorly understood.
The epithelial-to-mesenchymal transition (EMT) is an essential molecular process
involved in …
Evidence For The Involvement Of Runx1 And Runx2 In Maintenance Of The Breast Cancer Stem Cell Phenotype, Mark Fitzgerald
Evidence For The Involvement Of Runx1 And Runx2 In Maintenance Of The Breast Cancer Stem Cell Phenotype, Mark Fitzgerald
Graduate College Dissertations and Theses
In the United States, metastatic breast cancer kills approximately 40,000 women and 400 men annually, and approximately 200,000 new cases of breast cancer are diagnosed each year. Worldwide, breast cancer is the leading cause of cancer deaths among women. Despite advances in the detection and treatment of metastatic breast cancer, mortality rates from this disease remain high because the fact is that once metastatic, it is virtually incurable. It is widely accepted that a major reason breast cancer continues to exhibit recurrence after remission is that current therapies are insufficient for targeting and eliminating therapy-resistant cancer cells. Emerging research has …